Re: Corporate Update Webcast... 11:00 MT/1:00 ET... Link-->

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Corporate Update Webcast... 11:00 MT/1:00 ET... Link-->

posted on Jun 20, 2016 12:56PM

Slides are on the Zenith website now and also linked here and added to the link library/due diligence on the Zenith Agoracom hub.